 Ionis Pharmaceuticals Inc NASDAQ:IONS Director Breaux Castleman sold 10,000 shares of the firms stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of 60.00, for a total value of 600,000.00. Following the sale, the director now owns 25,183 shares of the companys stock, valued at approximately ... 